Automated Insulin Delivery for Inpatients With Dysglycemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT06418880
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 130 participants
- Registry
-
NCT06418880
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06418880. Randomized; no masking; primary purpose treatment. Start 2025-01-22 (actual); primary completion 2025-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Automated Insulin Delivery for Inpatients With Dysglycemia
- Acronym
- AIDING
- Condition
- Type 1 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Device)
- AID system with Remote Real-Time CGM
- Intervention (Combination product)
- Standard of Care Insulin Therapy + CGM
- Lead sponsor
- Emory University
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct06418880- Content hash
622d910d703339ffc1f2c9e1d568dc1610c9e2b1624fa1bb7ca65348f9904359